Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF502 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZIK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SERP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST6GAL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR7-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TBC1D2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCDC2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR10D1P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCTD19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM131 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100126784 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on